Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing - PubMed (original) (raw)

. 2012 Dec;44(12):1316-20.

doi: 10.1038/ng.2469. Epub 2012 Nov 11.

Matthias Schlesner, Steve Hoffmann, Markus Kreuz, Ellen Leich, Birgit Burkhardt, Maciej Rosolowski, Ole Ammerpohl, Rabea Wagener, Stephan H Bernhart, Dido Lenze, Monika Szczepanowski, Maren Paulsen, Simone Lipinski, Robert B Russell, Sabine Adam-Klages, Gordana Apic, Alexander Claviez, Dirk Hasenclever, Volker Hovestadt, Nadine Hornig, Jan O Korbel, Dieter Kube, David Langenberger, Chris Lawerenz, Jasmin Lisfeld, Katharina Meyer, Simone Picelli, Jordan Pischimarov, Bernhard Radlwimmer, Tobias Rausch, Marius Rohde, Markus Schilhabel, René Scholtysik, Rainer Spang, Heiko Trautmann, Thorsten Zenz, Arndt Borkhardt, Hans G Drexler, Peter Möller, Roderick A F MacLeod, Christiane Pott, Stefan Schreiber, Lorenz Trümper, Markus Loeffler, Peter F Stadler, Peter Lichter, Roland Eils, Ralf Küppers, Michael Hummel, Wolfram Klapper, Philip Rosenstiel, Andreas Rosenwald, Benedikt Brors, Reiner Siebert; ICGC MMML-Seq Project

Collaborators, Affiliations

• PMID: 23143595
• DOI: 10.1038/ng.2469

Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing

Julia Richter et al. Nat Genet. 2012 Dec.

Abstract

Burkitt lymphoma is a mature aggressive B-cell lymphoma derived from germinal center B cells. Its cytogenetic hallmark is the Burkitt translocation t(8;14)(q24;q32) and its variants, which juxtapose the MYC oncogene with one of the three immunoglobulin loci. Consequently, MYC is deregulated, resulting in massive perturbation of gene expression. Nevertheless, MYC deregulation alone seems not to be sufficient to drive Burkitt lymphomagenesis. By whole-genome, whole-exome and transcriptome sequencing of four prototypical Burkitt lymphomas with immunoglobulin gene (IG)-MYC translocation, we identified seven recurrently mutated genes. One of these genes, ID3, mapped to a region of focal homozygous loss in Burkitt lymphoma. In an extended cohort, 36 of 53 molecularly defined Burkitt lymphomas (68%) carried potentially damaging mutations of ID3. These were strongly enriched at somatic hypermutation motifs. Only 6 of 47 other B-cell lymphomas with the IG-MYC translocation (13%) carried ID3 mutations. These findings suggest that cooperation between ID3 inactivation and IG-MYC translocation is a hallmark of Burkitt lymphomagenesis.

PubMed Disclaimer

Similar articles

• The genetic landscape of mutations in Burkitt lymphoma.
  Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy CH, Choi WW, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers CR, Naresh KN, Evens AM, Chadburn A, Gordon LI, Czader MB, Gill JI, Hsi ED, Greenough A, Moffitt AB, McKinney M, Banerjee A, Grubor V, Levy S, Dunson DB, Dave SS. Love C, et al. Nat Genet. 2012 Dec;44(12):1321-5. doi: 10.1038/ng.2468. Epub 2012 Nov 11. Nat Genet. 2012. PMID: 23143597 Free PMC article.
• Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
  Park SS, Kim JS, Tessarollo L, Owens JD, Peng L, Han SS, Tae Chung S, Torrey TA, Cheung WC, Polakiewicz RD, McNeil N, Ried T, Mushinski JF, Morse HC 3rd, Janz S. Park SS, et al. Cancer Res. 2005 Feb 15;65(4):1306-15. doi: 10.1158/0008-5472.CAN-04-0268. Cancer Res. 2005. PMID: 15735016
• A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma.
  Salaverria I, Martin-Guerrero I, Wagener R, Kreuz M, Kohler CW, Richter J, Pienkowska-Grela B, Adam P, Burkhardt B, Claviez A, Damm-Welk C, Drexler HG, Hummel M, Jaffe ES, Küppers R, Lefebvre C, Lisfeld J, Löffler M, Macleod RA, Nagel I, Oschlies I, Rosolowski M, Russell RB, Rymkiewicz G, Schindler D, Schlesner M, Scholtysik R, Schwaenen C, Spang R, Szczepanowski M, Trümper L, Vater I, Wessendorf S, Klapper W, Siebert R; Molecular Mechanisms in Malignant Lymphoma Network Project; Berlin-Frankfurt-Münster Non-Hodgkin Lymphoma Group. Salaverria I, et al. Blood. 2014 Feb 20;123(8):1187-98. doi: 10.1182/blood-2013-06-507996. Epub 2014 Jan 7. Blood. 2014. PMID: 24398325 Free PMC article.
• Mature B-cell leukemias with more than 55% prolymphocytes: report of 2 cases with Burkitt lymphoma-type chromosomal translocations involving c-myc.
  Merchant S, Schlette E, Sanger W, Lai R, Medeiros LJ. Merchant S, et al. Arch Pathol Lab Med. 2003 Mar;127(3):305-9. doi: 10.5858/2003-127-0305-MBCLWM. Arch Pathol Lab Med. 2003. PMID: 12653573 Review.
• New clues to the molecular pathogenesis of Burkitt lymphoma revealed through next-generation sequencing.
  Greenough A, Dave SS. Greenough A, et al. Curr Opin Hematol. 2014 Jul;21(4):326-32. doi: 10.1097/MOH.0000000000000059. Curr Opin Hematol. 2014. PMID: 24867287 Review.

Cited by

• HYENA detects oncogenes activated by distal enhancers in cancer.
  Yu A, Yesilkanal AE, Thakur A, Wang F, Yang Y, Phillips W, Wu X, Muir A, He X, Spitz F, Yang L. Yu A, et al. Nucleic Acids Res. 2024 Sep 9;52(16):e77. doi: 10.1093/nar/gkae646. Nucleic Acids Res. 2024. PMID: 39051548 Free PMC article.
• The tumor microenvironment shapes hallmarks of mature B-cell malignancies.
  Shain KH, Dalton WS, Tao J. Shain KH, et al. Oncogene. 2015 Sep 3;34(36):4673-82. doi: 10.1038/onc.2014.403. Epub 2015 Feb 2. Oncogene. 2015. PMID: 25639873 Free PMC article. Review.
• Lessons from next-generation sequencing analysis in hematological malignancies.
  Braggio E, Egan JB, Fonseca R, Stewart AK. Braggio E, et al. Blood Cancer J. 2013 Jul 19;3(7):e127. doi: 10.1038/bcj.2013.26. Blood Cancer J. 2013. PMID: 23872706 Free PMC article.
• Treatment of adolescents with aggressive B-cell malignancies: the pediatric experience.
  Lange J, Burkhardt B. Lange J, et al. Curr Hematol Malig Rep. 2013 Sep;8(3):226-35. doi: 10.1007/s11899-013-0166-1. Curr Hematol Malig Rep. 2013. PMID: 23812872 Review.
• Integrating understanding of epidemiology and genomics in B-cell non-Hodgkin lymphoma as a pathway to novel management strategies.
  Glass S, Phan A, Williams JN, Flowers CR, Koff JL. Glass S, et al. Discov Med. 2016 Mar;21(115):181-8. Discov Med. 2016. PMID: 27115168 Free PMC article. Review.

References

1. 1. Bioinformatics. 2012 Sep 15;28(18):i333-i339 - PubMed
2. 1. J Mol Biol. 1993 Dec 5;234(3):779-815 - PubMed
3. 1. Leukemia. 2003 Dec;17(12):2257-317 - PubMed
4. 1. Bioinformatics. 2012 Feb 1;28(3):423-5 - PubMed
5. 1. Nature. 2012 Aug 2;488(7409):100-5 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • NIAID Data Ecosystem - Find datasets on Infectious and Immune-mediated Diseases
  • The Weizmann Institute of Science GeneCards and MalaCards databases